Elsevier Appoints Industry Leader Omry Bigger as President of its Global Clinical Solutions Business Unit
2024年9月18日
Elsevier 打開新的分頁/視窗 Health, a global leader in medical information and data analytics, today announced the appointment of Mr. Omry Bigger as President, Clinical Solutions at Elsevier Health. He joins Elsevier from LexisNexis Legal & Professional, another part of RELX, a leading global provider of information-based analytic tools.
Omry brings over 14 years of leadership experience from LexisNexis Legal & Professional, where he served as SVP, Large Markets at LexisNexis North America.
Notably, Omry played a pivotal role in the successful commercial roll-out of Lexis+ AI, the first Generative AI offering across RELX. Under Omry’s leadership, the Clinical Solutions business will aim to further strengthen its portfolio of trusted products supporting clinicians across the world, including the recently launched ClinicalKey AI.
Jan Herzhoff, President of Elsevier Health said: “With his extensive expertise in commercial go-to-market activities, highly competitive markets, and generative AI, Omry is well-equipped to lead Elsevier's Clinical Solutions business toward accelerated growth. His deep understanding of customer needs and his ability to deliver innovative solutions will be invaluable as we continue to enhance our portfolio and drive growth.”
Commenting on his appointment, Omry said: “I am delighted to be joining Elsevier Health at such an exciting time for the business. We are well positioned to take advantage of the many opportunities provided by AI in healthcare, and I look forward in working with the highly skilled and dedicated Clinical Solutions team to deliver exceptional value to customers, and ultimately, to improve patient outcomes.”
About Elsevier Health
For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.
Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.
關於 Elsevier
身為科學資訊與分析的全球領導者,Elsevier 協助研究人員與醫療照護專業人員推動科學發展,改善醫療成果,造福社會。我們以可信賴、以實證為基礎的內容和先進的 AI 數位技術為基礎,透過創新的解決方案促進洞察力和關鍵決策。
140 多年來,我們一直為研究和醫療保健界的工作提供支援。我們全球 9,500 名員工,包括 2,500 名技術人員,致力於支援研究人員、圖書館館長、學術領袖、資金提供者、政府、研發密集型公司、醫生、護士、未來醫療保健專業人員和教育工作者的重要工作。我們的 2,900 種科學期刊和經典參考工具書包括其領域中最重要的書籍,包括 Cell Press、The Lancet 和 Gray's Anatomy。 我們與愛思唯爾基金會 (Elsevier Foundation 打開新的分頁/視窗) 合作,與我們服務的社群攜手合作,在發展中國家和世界各地的科學、研究和醫療保健領域推動包容性和多樣性。 Elsevier 是 RELX 打開新的分頁/視窗 的一部分,RELX 打開新的分頁/視窗 是一家為專業和商業客戶提供以資訊為基礎的分析和決策工具的全球供應商。有關我們的工作、數位解決方案和內容的更多資訊,請造訪 www.elsevier.com 。